Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04814420 · ClinicalTrials.gov registry record · NA
Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study
A NA study of Atrial Fibrillation and Obstructive Sleep Apnea, sponsored by Tulane University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT04814420: Recruiting NA study of Atrial Fibrillation and Obstructive Sleep Apnea, sponsored by Tulane University.
NCT04814420 is a NA study of Atrial Fibrillation and Obstructive Sleep Apnea that is actively recruiting participants, run by Tulane University. The registered enrollment target is 60 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04814420, a NA study of Atrial Fibrillation and Obstructive Sleep Apnea, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove the presence of atrial fibrosis on Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) in OSA patients without atrial fibrillation (AF).
Primary Outcome
DE-MRI purpose is to quantify the degree of atrial structural remodeling or fibrosis Left Atrial Volume Max on MRI measurement reflects atrial load to provide insight into atrial remodeling Left Atrial Volume Min on MRI is important for understanding atrial function, particularly its ability to contract and expel blood into left ventricle Left Atrial Volume Index on MRI is an indicator of left atrial enlargement compared to raw volume measurements Left Atrial Emptying Fraction on MRI is a measur
Conditions Studied
Interventions
- DEVICE Delayed enhancement magnetic resonance imaging (DE-MRI)
Study Locations (3)
Louisiana
- East Jefferson General Hospital - New Orleans
- University Medical Center - New Orleans
- Tulane Doctors - Speciality Care - Napoleon - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-07-12 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT04814420 shows while recruiting
NCT04814420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Delayed enhancement magnetic resonance imaging (DE-MRI) is the first listed.
NCT04814420 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT04814420 about?
NCT04814420 is a clinical study titled "Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study". The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove the presence of atrial fibrosis on Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) in OSA patients without atrial fibrillation (AF).
What is the current status of trial NCT04814420?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-07-12. Estimated completion is 2026-07.
What conditions does trial NCT04814420 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Obstructive Sleep Apnea.
What interventions are being tested in trial NCT04814420?
The interventions under investigation include: Delayed enhancement magnetic resonance imaging (DE-MRI) (DEVICE).
Who is sponsoring clinical trial NCT04814420?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04814420 being conducted?
This trial has 3 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04814420's enrollment target sits among peer trials
60 166th of 202 higher than 33 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI